Philadelphia Trust CO Liquidia Corp Transaction History

Philadelphia Trust CO

  • $1.29 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
SELL
$5.77 - $12.19 $14,424 - $30,475
-2,500 Reduced 20.0%
10,000 $120,000
Q1 2022

May 05, 2022
SELL
$5.14 - $7.38 $12,850 - $18,450
-2,500 Reduced 16.67%
12,500 $90,000
Q1 2021

May 14, 2021
SELL
$2.42 - $3.6 $12,100 - $18,000
-5,000 Reduced 25.0%
15,000 $40,000
Q4 2020

Feb 08, 2021
BUY
$2.6 - $5.79 $52,000 - $115,800
20,000 New
20,000 $59,000

Others Institutions Holding LQDA

# of Institutions
162
Shares Held
36M
Call Options Held
1.79M
Put Options Held
380K
View Full List

About Liquidia Corp

LQDA Quotes by TradingView
  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Philadelphia Trust CO Portfolio

Follow Philadelphia Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Philadelphia Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email